definiens: ) . Syndax shall, within the time defined in theClinical Quality Agreement, perform ( i ) with respect to the Merck Compound, the acceptance procedures allocated toit under the Clinical Quality Agreement, and ( ii ) with respect to the Syndax Compound, the testing and releaseprocedures allocated to it under the Clinical Quality Agreement . Syndax shall take all steps necessary to determinethat the Syndax Compound or Merck Compound, as applicable, is suitable for release before making such SyndaxCompound or Merck Compound, as applicable, available for human use, and Merck shall provide cooperation orassistance as reasonably requested by Syndax in connection with such determination with respect to the MerckCompound . Syndax shall be responsible for storage and maintenance of the Merck Compound until it is tested and / orreleased, which storage and maintenance shall be in compliance with the Specifications for the Merck Compound, theClinical Quality Agreement and Applicable Law, and shall be responsible for any failure of the Merck Compound tomeet the Specifications to the extent caused by shipping, storage or handling conditions after Delivery to Syndaxhereunder